HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shitong Li Selected Research

Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)

1/2017Antioxidative and Antiapoptotic Effects of Delta-Opioid Peptide [D-Ala2, D-Leu5] Enkephalin on Spinal Cord Ischemia-Reperfusion Injury in Rabbits.
4/2016Dose-dependent neuroprotection of delta-opioid peptide [D-Ala(2), D-Leu(5)] enkephalin on spinal cord ischemia-reperfusion injury by regional perfusion into the abdominal aorta in rabbits.
1/2016Protective effect of delta opioid receptor agonist (D-Ala2, D-Leu5) enkephalin on permanent focal cerebral ischemia in rats.
1/2015Protective effect of delta opioid agonist [D-Ala2, D-Leu5] enkephalin on spinal cord ischemia reperfusion injury by regional perfusion into abdominal aorta in rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shitong Li Research Topics

Disease

7Ischemia
01/2020 - 01/2013
6Sepsis (Septicemia)
02/2022 - 01/2013
5Spinal Cord Ischemia
01/2020 - 01/2013
5Facial Nerve Injuries
11/2019 - 11/2013
4Reperfusion Injury
01/2017 - 01/2013
2Lung Injury
02/2022 - 05/2019
2Emergence Delirium
02/2021 - 10/2016
2Postoperative Cognitive Complications
02/2021 - 01/2018
2Pneumoperitoneum
04/2019 - 01/2017
2Delirium
10/2016 - 04/2016
2Inflammation (Inflammations)
02/2016 - 02/2015
2Pain (Aches)
06/2014 - 06/2002
1Apnea
01/2022
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2021
1Hypoxia (Hypoxemia)
02/2021
1Pulmonary Atelectasis
02/2021
1Hepatocellular Carcinoma (Hepatoma)
11/2020
1Cardiomegaly (Heart Hypertrophy)
01/2020
1Heart Failure
01/2020
1Hypertrophy
01/2020
1Hypertension (High Blood Pressure)
12/2019
1Pneumonia (Pneumonitis)
02/2018
1Pulmonary Edema
02/2018
1Muscular Diseases (Myopathy)
10/2017
1Respiratory Insufficiency (Respiratory Failure)
10/2017
1Critical Illness (Critically Ill)
10/2017
1Neuroinflammatory Diseases
10/2016
1Infarction (Infarctions)
01/2016
1Brain Ischemia (Cerebral Ischemia)
01/2016

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
09/2019 - 04/2013
4EnkephalinsIBA
01/2017 - 01/2015
4Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)IBA
01/2017 - 01/2015
3Rocuronium (Zemuron)FDA LinkGeneric
01/2022 - 11/2013
3HMGB1 Protein (HMG1)IBA
12/2020 - 01/2013
3salicylhydroxamic acid (SHAM)IBA
01/2020 - 01/2013
2LipopolysaccharidesIBA
02/2022 - 04/2013
2Therapeutic UsesIBA
02/2022 - 10/2016
2Anesthetics (Anesthetic Agents)IBA
01/2020 - 02/2016
2Opioid Peptides (Opioid Peptide)IBA
01/2017 - 04/2016
2Saline SolutionIBA
01/2017 - 06/2002
2Scopolamine (Hyoscine)FDA Link
10/2016 - 04/2016
2Messenger RNA (mRNA)IBA
10/2016 - 04/2013
2Homovanillic AcidIBA
10/2016 - 04/2016
2Serotonin (5 Hydroxytryptamine)IBA
10/2016 - 04/2016
2N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA
10/2016 - 04/2016
23,4-Dihydroxyphenylacetic AcidIBA
10/2016 - 04/2016
2Hydroxyindoleacetic AcidIBA
10/2016 - 04/2016
2CytokinesIBA
02/2015 - 04/2013
2Opioid Analgesics (Opioids)IBA
01/2015 - 06/2002
1Sirtuin 3IBA
02/2022
1Succinylcholine (Suxamethonium Chloride)FDA LinkGeneric
01/2022
1Methylene Blue (Methylthioninium Chloride)FDA Link
02/2021
1Toll-Like Receptor 4IBA
12/2020
1Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric
12/2020
1NF-kappa B (NF-kB)IBA
12/2020
1Long Noncoding RNAIBA
11/2020
1Lidocaine (Xylocaine)FDA LinkGeneric
01/2020
1DexmedetomidineFDA Link
01/2020
1peripheral membrane protein 43KIBA
11/2019
1muskIBA
11/2019
1AgrinIBA
11/2019
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
09/2019
1E-SelectinIBA
05/2019
1Biomarkers (Surrogate Marker)IBA
05/2019
1Plasminogen Activator Inhibitor 1IBA
05/2019
1Dinoprostone (PGE2)FDA Link
02/2018
1ArtesunateIBA
02/2018
1Interleukin-6 (Interleukin 6)IBA
02/2018
1Neuromuscular Blocking AgentsIBA
12/2017
1Adenosine Triphosphatases (ATPase)IBA
10/2017
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
10/2017
1CalciumIBA
10/2017
1Dihydrotachysterol (AT 10)IBA
01/2017
1Carbon DioxideIBA
01/2017
1InflammasomesIBA
10/2016
1Interleukin-8 (Interleukin 8)IBA
10/2016
1Neuroprotective AgentsIBA
10/2016
1Norepinephrine (Noradrenaline)FDA LinkGeneric
10/2016
1TOR Serine-Threonine KinasesIBA
04/2016
1Dopamine (Intropin)FDA LinkGeneric
04/2016
15-HT1A Serotonin ReceptorIBA
04/2016
1Neurotransmitter Agents (Neurotransmitter)IBA
04/2016
1KetamineFDA LinkGeneric
02/2016
1Analgesics (Analgesic Drugs)IBA
02/2016
1Hypnotics and Sedatives (Sedatives)IBA
02/2016
1delta Opioid Receptors (delta Opioid Receptor)IBA
01/2016
1Leucine EnkephalinIBA
01/2016
1triphenyltetrazoliumIBA
01/2016

Therapy/Procedure

6Anesthesia
10/2021 - 10/2014
2General Anesthesia
01/2018 - 10/2014
2Therapeutics
10/2016 - 01/2013
1Cesarean Section (Caesarean Section)
10/2021
1Positive-Pressure Respiration (Positive End-Expiratory Pressure)
02/2021
1One-Lung Ventilation
02/2021
1Artificial Respiration (Mechanical Ventilation)
12/2020
1Length of Stay
12/2019
1Ligation
10/2017
1Punctures
10/2017
1Injections
10/2016
1Intraperitoneal Injections
10/2016